Press "Enter" to skip to content

New patent expiration for Vicuron drug ERAXIS

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Vicuron drug ERAXIS

Annual Drug Patent Expirations for ERAXIS
Annual Drug Patent Expirations for ERAXIS

Eraxis is a drug marketed by Vicuron and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has sixty-four patent family members in twenty-nine countries.

The generic ingredient in ERAXIS is anidulafungin. One supplier is listed for this compound. Additional details are available on the anidulafungin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Vicuron drug ERAXIS
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions